Twist Bioscience Corporation (TWST) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 12.1B |
| Enterprise Value | 11.66B |
| P/E Ratio | -51.05 |
| PEG Ratio | 0.76 |
| Price/Sales Ratio | 15.22 |
| Price/Book Ratio | 7.49 |
| Enterprise/Revenue | 14.26 |
| Enterprise/EBITDA | -50.47 |
Fiscal Year
| Fiscal Year | September 30, 2026 |
| Most Recent Quarter | September 30, 2026 |
Profitability
| Profit Margin | -0.28 |
| Operating Margin | -0.3 |
AD
Management Effectiveness
| Return On Assets | -0.12 |
| Return On Equity | -0.23 |
Income Statement
| Revenue | 459.43M |
| Revenue/Share | 7.34 |
| Gross Profit | 240.8M |
| EBITDA | -129.8M |
| Net Income | -130.2M |
| Diluted EPS | -2.08 |
Balance Sheet
| Total Cash | 581.91M |
| Total Cash/Share | 9.29 |
| Total Debt | 94.99M |
| Total Debt/Equity | 0.11 |
| Current Ratio | 5.86 |
| Book Value Per Share | 14.18 |
Price History
| 52-Week Change | 237.25 |
| 52-Week High | 219.71 |
| 52-Week Low | 23.3 |
| Moving Average 50 Days | 150.9 |
| Moving Average 200 Days | 92.53 |
Statistics
| Average Volume | 2.37M |
| Shares Outstanding | 65.83M |
| % Held by Institutions | 124.73 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
